Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Common Equity (2023 - 2025)

Historic Common Equity for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $248.1 million.

  • Medical Group Holdings' Common Equity rose 2069.81% to $248.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $248.1 million, marking a year-over-year increase of 2069.81%. This contributed to the annual value of $195.1 million for FY2024, which is 3567.12% up from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' Common Equity is $248.1 million, which was up 2069.81% from $244.7 million recorded in Q2 2025.
  • Medical Group Holdings' 5-year Common Equity high stood at $248.1 million for Q3 2025, and its period low was -$5.2 million during Q2 2023.
  • Over the past 3 years, Medical Group Holdings' median Common Equity value was $169.5 million (recorded in 2023), while the average stood at $127.3 million.
  • Over the last 5 years, Medical Group Holdings' Common Equity had its largest YoY gain of 267052.03% in 2025, and its largest YoY loss of 2069.81% in 2025.
  • Quarter analysis of 3 years shows Medical Group Holdings' Common Equity stood at $143.8 million in 2023, then skyrocketed by 35.67% to $195.1 million in 2024, then increased by 27.14% to $248.1 million in 2025.
  • Its Common Equity stands at $248.1 million for Q3 2025, versus $244.7 million for Q2 2025 and $226.4 million for Q1 2025.